Chemexpress(SH:688131)2023-11-16 07:56Group 1: Company Overview - Shanghai Haoyuan Pharmaceutical Co., Ltd. is listed under stock code 688131 and stock name Haoyuan Pharmaceutical [2][3] - The company is located at 1999 Zhangheng Road, Building 3, Pudong New District, Shanghai, 201203 [1][4] Group 2: Q3 2023 Financial Performance - For the first three quarters of 2023, the company achieved total operating revenue of 1.376 billion CNY, an increase of 41.84% compared to the same period last year [4] - In Q3 2023 alone, the company reported operating revenue of 495 million CNY, reflecting a year-on-year growth of 41.95% [4] - The front-end business generated revenue of 232 million CNY, up 30.26% year-on-year; while tool compounds revenue reached 620 million CNY, increasing by 46.49% [4] - The back-end business saw innovative drug revenue of 331 million CNY, a growth of 54.40%, and generic drug revenue of 184 million CNY, up 25.60% [4]